人工角膜和角膜植入市場規模、佔有率、成長分析（按類型、按植入物類型、按適應症、按最終用戶、按地區）- 行業預測，2025 年至 2032 年

2023 年全球人工角膜和角膜植入市場規模價值 4.542 億美元，預計將從 2024 年的 4.8781 億美元成長到 2032 年的 8.6355 億美元，預計在預測期內到 2032 年將達到 14 億美元（ 2025 -2026年）。

由於眼部疾病盛行率的上升和眼部保健投資需求的增加，人工角膜和角膜植入市場預計將顯著成長。人們對眼角膜捐贈認知的不斷提高和器官捐贈登記數量的激增進一步推動了市場擴張。此外，增加獲得可靠的眼部移植手術的機會以及改善眼科護理的報銷政策預計也將推動銷售。然而，這些植入的高成本可能會阻礙某些地區的市場發展。值得注意的是，全球老年人口的快速成長對人工角膜和角膜植入產生了持續的需求，未來幾年市場將呈現長期成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

人工角膜和角膜植入市場規模（按類型）

• 市場概況
• 人類角膜
• 人工角膜

人工角膜和角膜植入市場規模（以植入物類型）

• 市場概況
• 穿透性角膜移植術
• 內皮角膜移植手術
• 前板層角膜移植手術
• 人工替代物

人工角膜和角膜植入市場規模（依適應症）

• 市場概況
• 福克斯營養不良症
• 黴菌性角膜炎
• 圓錐角膜
• 其他

人工角膜和角膜植入市場規模（依最終用戶）

• 市場概況
• 醫院及門診手術中心
• 專科門診

人工角膜和角膜植入市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• CorNeat Vision（Israel）
• KeraMed, Inc.（USA）
• LinkoCare Life Sciences AB（Sweden）
• DIOPTEX GmbH（Austria）
• EyeYon Medical（Israel）
• AJL Ophthalmic SA（Spain）
• Mediphacos（Brazil）
• CorneaGen（USA）
• Florida Lions Eye Bank（USA）
• San Diego Eye Bank（USA）
• Alabama Eye Bank（USA）
• Massachusetts Eye and Ear（USA）
• Advancing Sight Network（USA）
• LV Prasad Eye Institute（LVPEI, India）
• Alcon Inc.（Switzerland）
• Aurolab（India）
• Cornea Biosciences（USA）
• Price Vision Group（USA）

結論和建議

Global Artificial Cornea and Corneal Implant Market size was valued at USD 454.2 million in 2023 and is poised to grow from USD 487.81 million in 2024 to USD 863.55 million by 2032, growing at a CAGR of 7.4% during the forecast period (2025-2032).

The artificial cornea and corneal implant market is anticipated to experience significant growth due to the rising prevalence of ophthalmic diseases and an increasing consumer willingness to invest in eye care. Heightened awareness of eye donation and a surge in organ donor registries are further fueling market expansion. Additionally, enhanced access to reliable eye transplant procedures and improved reimbursement policies for eye care are expected to drive sales. However, high costs associated with these implants in certain regions may hinder market development. Notably, the rapidly growing geriatric population worldwide will create sustained demand for artificial corneas and corneal implants, positioning the market for long-term growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Cornea And Corneal Implant market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Cornea And Corneal Implant Market Segmental Analysis

Global Artificial Cornea and Corneal Implant Market is segmented by Type, Transplant Type, Disease Indication, End User and region. Based on Type, the market is segmented into Human Cornea and Artificial Cornea. Based on Transplant Type, the market is segmented into Penetrating Keratoplasty, Endothelial Keratoplasty, Anterior lamellar keratoplasty and keratoprosthesis. Based on Disease Indication, the market is segmented into Fuchs' Dystrophy, Fungal Keratitis, Keratoconus and Others. Based on End User, the market is segmented into Hospitals & Ambulatory Surgical Centers and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Artificial Cornea And Corneal Implant Market

The rising incidence of corneal disorders is a significant driver for the Global Artificial Cornea and Corneal Implant market. This increase can be attributed to both an aging population and greater exposure to screens, which have heightened the occurrence of these conditions globally. As the need for corneal transplants grows in response to these disorders, there will be an escalated demand for artificial corneas and corneal implants. Consequently, advancements in technology and medical procedures are expected to further spur market growth, addressing the needs arising from this escalating health concern.

Restraints in the Global Artificial Cornea And Corneal Implant Market

One significant constraint facing the Global Artificial Cornea and Corneal Implant market is the limited reimbursement options for corneal transplantation procedures. Many healthcare insurance plans do not comprehensively cover these surgeries, forcing patients to bear the high costs out-of-pocket. This financial burden often discourages individuals from pursuing such critical procedures, ultimately hindering market growth. The high expenses associated with corneal transplants create a barrier that could prevent broader accessibility and adoption, limiting the potential for advancements and expansions within the artificial cornea and implant sector. As a result, the market may struggle to thrive amid these financial challenges.

Market Trends of the Global Artificial Cornea And Corneal Implant Market

The Global Artificial Cornea and Corneal Implant market is increasingly trending towards the adoption of minimally invasive surgical techniques, as patients prioritize quicker recovery times and reduced surgical risks. This shift has prompted product developers to innovate and streamline their offerings, making advanced corneal solutions more accessible to both surgeons and patients. Additionally, enhancing reimbursement policies for these procedures is becoming critical, as it can significantly boost the uptake of artificial corneas and implants. As healthcare systems evolve to support these trends, market players must adapt their strategies to capitalize on the growing demand for effective, less invasive ocular treatments.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Artificial Cornea and Corneal Implant Market Size by Type & CAGR (2025-2032)

• Market Overview
• Human Cornea
• Artificial Cornea

Global Artificial Cornea and Corneal Implant Market Size by Transplant Type & CAGR (2025-2032)

• Market Overview
• Penetrating Keratoplasty
• Endothelial Keratoplasty
• Anterior lamellar keratoplasty
• keratoprosthesis

Global Artificial Cornea and Corneal Implant Market Size by Disease Indication & CAGR (2025-2032)

• Market Overview
• Fuchs' Dystrophy
• Fungal Keratitis
• Keratoconus
• Others

Global Artificial Cornea and Corneal Implant Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Ambulatory Surgical Centers
• Specialty Clinics

Global Artificial Cornea and Corneal Implant Market Size & CAGR (2025-2032)

• North America (Type, Transplant Type, Disease Indication, End User)
  • US
  • Canada
• Europe (Type, Transplant Type, Disease Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Transplant Type, Disease Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Transplant Type, Disease Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Transplant Type, Disease Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• CorNeat Vision (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KeraMed, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LinkoCare Life Sciences AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DIOPTEX GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EyeYon Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AJL Ophthalmic SA (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediphacos (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CorneaGen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Florida Lions Eye Bank (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• San Diego Eye Bank (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alabama Eye Bank (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Massachusetts Eye and Ear (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advancing Sight Network (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• L V Prasad Eye Institute (LVPEI, India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcon Inc. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurolab (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cornea Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Price Vision Group (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations